Voya Investment Management LLC raised its stake in Maximus, Inc. (NYSE:MMS) by 10.9% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 29,734 shares of the health services provider’s stock after purchasing an additional 2,932 shares during the quarter. Voya Investment Management LLC’s holdings in Maximus were worth $1,862,000 at the end of the most recent quarter.
A number of other large investors also recently added to or reduced their stakes in the business. BlackRock Inc. raised its position in Maximus by 22,491.0% in the first quarter. BlackRock Inc. now owns 6,503,511 shares of the health services provider’s stock valued at $404,518,000 after purchasing an additional 6,474,723 shares during the period. Vanguard Group Inc. raised its position in Maximus by 2.4% in the second quarter. Vanguard Group Inc. now owns 5,669,026 shares of the health services provider’s stock valued at $355,052,000 after purchasing an additional 130,839 shares during the period. FMR LLC raised its position in Maximus by 10.4% in the second quarter. FMR LLC now owns 4,658,584 shares of the health services provider’s stock valued at $291,767,000 after purchasing an additional 438,025 shares during the period. Victory Capital Management Inc. raised its position in Maximus by 8.6% in the second quarter. Victory Capital Management Inc. now owns 3,100,903 shares of the health services provider’s stock valued at $194,210,000 after purchasing an additional 244,823 shares during the period. Finally, State Street Corp raised its position in Maximus by 2.5% in the first quarter. State Street Corp now owns 2,066,226 shares of the health services provider’s stock valued at $128,517,000 after purchasing an additional 50,670 shares during the period. 97.25% of the stock is currently owned by institutional investors.
Shares of Maximus, Inc. (MMS) opened at 65.88 on Friday. The stock’s 50 day moving average price is $64.40 and its 200 day moving average price is $62.21. The firm has a market capitalization of $4.27 billion, a P/E ratio of 21.12 and a beta of 1.36. Maximus, Inc. has a 52 week low of $43.69 and a 52 week high of $66.65.
Maximus (NYSE:MMS) last released its earnings results on Thursday, August 3rd. The health services provider reported $0.79 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.76 by $0.03. The firm had revenue of $600.40 million during the quarter, compared to analyst estimates of $614.12 million. Maximus had a net margin of 8.43% and a return on equity of 25.08%. The business’s revenue was down 2.7% on a year-over-year basis. During the same quarter in the previous year, the business earned $0.79 EPS. On average, analysts predict that Maximus, Inc. will post $3.13 EPS for the current fiscal year.
The business also recently disclosed a quarterly dividend, which will be paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th will be given a dividend of $0.045 per share. This represents a $0.18 dividend on an annualized basis and a dividend yield of 0.27%. The ex-dividend date of this dividend is Tuesday, November 14th. Maximus’s dividend payout ratio is currently 5.73%.
WARNING: This news story was originally published by Dispatch Tribunal and is owned by of Dispatch Tribunal. If you are accessing this news story on another site, it was illegally copied and reposted in violation of US & international copyright and trademark law. The correct version of this news story can be accessed at https://www.dispatchtribunal.com/2017/10/28/maximus-inc-mms-position-raised-by-voya-investment-management-llc.html.
In other news, General Counsel David Francis sold 3,000 shares of the company’s stock in a transaction dated Thursday, October 5th. The shares were sold at an average price of $65.28, for a total transaction of $195,840.00. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Richard A. Montoni sold 29,203 shares of the company’s stock in a transaction dated Thursday, August 17th. The shares were sold at an average price of $60.38, for a total transaction of $1,763,277.14. Following the transaction, the chief executive officer now directly owns 549,215 shares of the company’s stock, valued at approximately $33,161,601.70. The disclosure for this sale can be found here. Insiders have sold 143,403 shares of company stock valued at $8,866,281 in the last ninety days. 3.10% of the stock is owned by company insiders.
Several research firms have commented on MMS. Zacks Investment Research lowered Maximus from a “buy” rating to a “hold” rating in a research report on Tuesday, October 10th. Robert W. Baird began coverage on Maximus in a research report on Sunday, September 3rd. They issued a “neutral” rating on the stock. Maxim Group set a $66.00 target price on Maximus and gave the company a “hold” rating in a research note on Thursday, August 3rd. Finally, BidaskClub downgraded Maximus from a “hold” rating to a “sell” rating in a research note on Monday, July 24th. One analyst has rated the stock with a sell rating and nine have assigned a hold rating to the stock. The stock currently has an average rating of “Hold” and a consensus price target of $63.14.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with MarketBeat.com's FREE daily email newsletter.